miR-9-3 was a tumor suppressor miRNA hypermethylated in CLL, which was associated with down-regulation of NFκB1 protein, and hence might contribute to constitutive activation of NFκB signaling pathway in CLL. The gene discussed is NFKB1; the disease is B-cell chronic lymphocytic leukemia.